Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19
NEW YORK and SYDNEY, October 19, 2020, Beroni Group (“Beroni”) announced successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation (“GenScript”), a leading global biotechnology company.…